Table 3.
Adjusted odds ratio
| Outcome | No corticosteroids (number/total (%)) | Corticosteroids (number/total (%)) | Estimate (95% CI) | P value |
|---|---|---|---|---|
| In‐hospital death | 179/831 (22) | 125/480 (26) | 1.04 (0.81–1.34) | 0.74 |
| In‐hospital death in NIMV patients | 85/187 (45) | 83/203 (41) | 0.79 (0.53–1.17) | 0.24 |
| In‐hospital death in patients not receiving NIMV (with/without oxygen) | 94/644 (15) | 42/277 (15) | 0.95 (0.66–1.35) | 0.78 |
| ICU admission | 56/831 (7) | 53/480 (11) | 0.81 (0.56–1.17) | 0.26 |
| ICU admission in NIMV patients | 38/187 (20 ) | 41/203 (20) | 0.58 (0.35–0.94) | 0.03 |
| ICU admission in patients not receiving NIMV (with/without oxygen) | 18/644 (3) | 18/277 (6) | 0.88 (0.45–1.70) | 0.71 |
Patients on NIMV are patients with a score of 5 on the WHO COVID‐19 Ordinal Scale For Clinical Improvement; patients not receiving NIMV are patients with a score of 3 and 4 on the WHO COVID‐19 Ordinal Scale For Clinical Improvement.
CI, confidence interval; ICU, intensive care unit; NIMV, noninvasive mechanical ventilation.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.